CNS Pharmaceuticals Inc. (CNSP) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    CNS Pharmaceuticals Inc.

    NASDAQ: CNSP · Real-Time Price · USD
    8.96
    0.08 (0.90%)
    At close: Oct 03, 2025, 3:59 PM
    8.88
    -0.84%
    After-hours: Oct 03, 2025, 07:20 PM EDT

    CNS Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 6.46M 548.72K 10.06M 5M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 36.43K 104.75K 482.81K 1.26M
    Receivables
    		 882.54K n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 1.31M 202.86K n/a n/a
    Total Current Assets
    		 8.66M 1.59M 12.56M 7.48M
    Property-Plant & Equipment
    		 6K 4.93K 5.66K 16.11K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 42.44K 109.68K 488.47K 1.28M
    Total Assets
    		 8.7M 1.7M 13.05M 8.76M
    Account Payables
    		 2.2M 5.83M 3.68M 1.98M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 326.07K 300.81K 409.97K 387.79K
    Other Current Liabilities
    		 n/a n/a n/a n/a
    Total Current Liabilities
    		 2.52M 6.13M 4.92M 2.59M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Liabilities
    		 2.52M 6.13M 4.92M 2.14M
    Total Debt
    		 326.07K 300.81K 409.97K 387.79K
    Book Value
    		 6.18M -4.43M 8.13M 6.62M
    Book Value Per Share
    		 19.47 -0.71 3.60 4.69
    Common Stock
    		 1.41K 6.21K 1.62K 27.93K
    Retained Earnings
    		 -84.42M -69.57M -50.72M -34.98M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 6.18M -4.43M 8.13M 6.62M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist